S 3729 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
PBM Reporting Transparency Act
To require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans.
Summary
This bill requires the Medicare Payment Advisory Commission to submit two reports to Congress analyzing agreements between pharmacy benefit managers and Medicare prescription drug plans and Medicare Advantage prescription drug plans. The initial report, due approximately two years after relevant data becomes available to the Commission, must analyze trends in these agreements and their effects on out-of-pocket costs for plan enrollees and pharmacy reimbursement rates. A final report is due two years after the initial report describing any changes in these agreements over time. Both reports must include recommendations the Commission deems appropriate. The reports are intended to provide Congress with information about pharmacy benefit manager practices and their impacts on Medicare beneficiaries.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Sen. Warner, Mark R. [D-VA] (D-VA)
3 cosponsors
Actions (2)
- Jan 29, 2026 Read twice and referred to the Committee on Finance. · senate
- Jan 29, 2026 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
January 29, 2026
Mr. Warner (for himself, Mr. Tillis, Ms. Cortez Masto, and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “PBM Reporting Transparency Act”.
SEC. 2. MEDPAC REPORTS ON AGREEMENTS WITH PHARMACY BENEFIT MANAGERS WITH RESPECT TO PRESCRIPTION DRUG PLANS AND MA-PD PLANS.
The Medicare Payment Advisory Commission shall submit to Congress the following reports:
(1) Initial report.—Not later than the first March 15 occurring after the date that is 2 years after the date on which the Secretary makes the data available to the Commission, a report regarding agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans. Such report shall include, to the extent practicable—
(A) a description of trends and patterns, including relevant averages, totals, and other figures for the types of information submitted;
(B) an analysis of any differences in agreements and their effects on plan enrollee out-of-pocket spending and average pharmacy reimbursement, and other impacts; and
(C) any recommendations the Commission determines appropriate.
(2) Final report.—Not later than 2 years after the date on which the Commission submits the initial report under paragraph
(1), a report describing any changes with respect to the information described in paragraph (1) over time, together with any recommendations the Commission determines appropriate. <all>
Comments